Title : Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study - Rosenstock_2006_Clin.Ther_28_1556 |
Author(s) : Rosenstock J , Brazg R , Andryuk PJ , Lu K , Stein P |
Ref : Clin Ther , 28 :1556 , 2006 |
Abstract : |
PubMedSearch : Rosenstock_2006_Clin.Ther_28_1556 |
PubMedID: 17157112 |